<table id="_RefIDAF140429BB184EA18A32EBF8F812D280" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1. Select Mean (± S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin </caption>
<col width="2%"></col>
<col width="41%"></col>
<col width="14%"></col>
<col width="14%"></col>
<col width="19%"></col>
<thead>
<tr stylecode="Toprule">
<th align="center" colspan="2" valign="top">
<content stylecode="bold">Subject Groups: metformin</content>
</th>
<th align="center" valign="top">
<content stylecode="bold">C<sub>max</sub>
<sup>b</sup>
</content>
</th>
<th align="center" valign="top">
<content stylecode="bold">T<sub>max</sub>
<sup>c</sup>
</content>
</th>
<th align="center" valign="top">
<content stylecode="bold">Renal Clearance</content>
</th>
</tr>
<tr>
<th align="center" colspan="2" valign="top">
<content stylecode="bold">dose<sup>a</sup> (number of subjects)</content>
</th>
<th align="center" valign="top">
<content stylecode="bold">(mcg/mL)</content>
</th>
<th align="center" valign="top">
<content stylecode="bold">(hrs)</content>
</th>
<th align="center" valign="top">
<content stylecode="bold">(mL/min)</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="2">
<paragraph>
<content stylecode="bold">Healthy, nondiabetic adults:</content>
</paragraph>
</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>
<paragraph>500 mg single dose (24)</paragraph>
</td>
<td align="center">
<paragraph>1.03 (± 0.33)</paragraph>
</td>
<td align="center">
<paragraph>2.75 (± 0.81)</paragraph>
</td>
<td align="center">
<paragraph>600 (± 132)</paragraph>
</td>
</tr>
<tr>
<td></td>
<td>
<paragraph>850 mg single dose (74)<sup>d</sup>
</paragraph>
</td>
<td align="center">
<paragraph>1.60 (± 0.38)</paragraph>
</td>
<td align="center">
<paragraph>2.64 (± 0.82)</paragraph>
</td>
<td align="center">
<paragraph>552 (± 139)</paragraph>
</td>
</tr>
<tr>
<td></td>
<td>
<paragraph>850 mg three times daily for 19 doses<sup>e</sup> (9)</paragraph>
</td>
<td align="center">
<paragraph>2.01 (± 0.42)</paragraph>
</td>
<td align="center">
<paragraph>1.79 (± 0.94)</paragraph>
</td>
<td align="center">
<paragraph>642 (± 173)</paragraph>
</td>
</tr>
<tr>
<td colspan="2">
<paragraph>
<content stylecode="bold">Adults with type 2 diabetes:</content>
</paragraph>
</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>
<paragraph>850 mg single dose (23)</paragraph>
</td>
<td align="center">
<paragraph>1.48 (± 0.5)</paragraph>
</td>
<td align="center">
<paragraph>3.32 (± 1.08)</paragraph>
</td>
<td align="center">
<paragraph>491 (± 138)</paragraph>
</td>
</tr>
<tr>
<td></td>
<td>
<paragraph>850 mg three times daily for 19 doses<sup>e</sup> (9)</paragraph>
</td>
<td align="center">
<paragraph>1.90 (± 0.62)</paragraph>
</td>
<td align="center">
<paragraph>2.01 (± 1.22)</paragraph>
</td>
<td align="center">
<paragraph>550 (± 160)</paragraph>
</td>
</tr>
<tr>
<td colspan="2">
<paragraph>
<content stylecode="bold">Elderly<sup>f</sup>, healthy nondiabetic adults:</content>
</paragraph>
</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>
<paragraph>850 mg single dose (12)</paragraph>
</td>
<td align="center">
<paragraph>2.45 (± 0.70)</paragraph>
</td>
<td align="center">
<paragraph>2.71 (± 1.05)</paragraph>
</td>
<td align="center">
<paragraph>412 (± 98)</paragraph>
</td>
</tr>
<tr>
<td colspan="2">
<paragraph>
<content stylecode="bold">Renal-impaired adults:</content> 850 mg single dose</paragraph>
</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>
<paragraph>
<content stylecode="bold">Mild</content> (CL<sub>cr</sub>
<sup>g</sup> 61-90 mL/min) (5)</paragraph>
</td>
<td align="center">
<paragraph>1.86 (± 0.52)</paragraph>
</td>
<td align="center">
<paragraph>3.20 (± 0.45)</paragraph>
</td>
<td align="center">
<paragraph>384 (± 122)</paragraph>
</td>
</tr>
<tr>
<td></td>
<td>
<paragraph>
<content stylecode="bold">Moderate</content> (CL<sub>cr</sub> 31-60 mL/min) (4)</paragraph>
</td>
<td align="center">
<paragraph>4.12 (± 1.83)</paragraph>
</td>
<td align="center">
<paragraph>3.75 (± 0.50)</paragraph>
</td>
<td align="center">
<paragraph>108 (± 57)</paragraph>
</td>
</tr>
<tr>
<td></td>
<td>
<paragraph>
<content stylecode="bold">Severe</content> (CL<sub>cr</sub> 10-30 mL/min) (6)</paragraph>
</td>
<td align="center">
<paragraph>3.93 (± 0.92)</paragraph>
</td>
<td align="center">
<paragraph>4.01 (± 1.10)</paragraph>
</td>
<td align="center">
<paragraph>130 (± 90)</paragraph>
</td>
</tr>
<tr>
<td colspan="5">
<paragraph>
<sup>a</sup>–All doses given fasting except the first 18 doses of the multiple dose studies;</paragraph>
</td>
</tr>
<tr>
<td colspan="5">
<paragraph>
<sup>b</sup>–Peak plasma concentration;</paragraph>
</td>
</tr>
<tr>
<td colspan="5">
<paragraph>
<sup>c</sup>–Time to peak plasma concentration;</paragraph>
</td>
</tr>
<tr>
<td colspan="5">
<paragraph>
<sup>d</sup>–Combined results (average means) of five studies: mean age 32 years (range 23-59 years).</paragraph>
</td>
</tr>
<tr>
<td colspan="5">
<paragraph>
<sup>e</sup>–Kinetic study done following dose 19, given fasting.</paragraph>
</td>
</tr>
<tr>
<td colspan="5">
<paragraph>
<sup>f</sup>–Elderly subjects, mean age 71 years (range 65-81 years).</paragraph>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="5">
<paragraph>
<sup>g</sup>–CL<sub>cr</sub> = creatinine clearance normalized to body surface area of 1.73 m<sup>2</sup>.</paragraph>
</td>
</tr>
</tbody>
</table>